$277 Million is the total value of ACUTA CAPITAL PARTNERS, LLC's 46 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 60.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VTGN | Buy | VISTAGEN THERAPEUTICS INC | $26,190,000 | +80.0% | 12,295,767 | +63.9% | 9.44% | +138.5% |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $20,961,000 | -26.5% | 1,017,524 | -37.5% | 7.56% | -2.6% |
| KURA | Sell | KURA ONCOLOGY INC | $15,176,000 | -27.1% | 536,820 | -15.8% | 5.47% | -3.4% |
| AVDL | Buy | AVADEL PHARMACEUTICALS PLCsponsored adr | $9,899,000 | +110.1% | 1,095,000 | +55.3% | 3.57% | +178.4% |
| ISEE | Buy | IVERIC BIO INC | $9,759,000 | +16.5% | 1,579,093 | +30.2% | 3.52% | +54.3% |
| ETNB | Sell | 89BIO INC | $9,319,000 | -12.0% | 393,548 | -9.4% | 3.36% | +16.6% |
| BLSA | Buy | BCLS ACQUISITION CORP | $8,912,000 | -5.0% | 843,122 | +0.1% | 3.21% | +25.8% |
| SAGE | Sell | SAGE THERAPEUTICS INC | $8,870,000 | -59.9% | 118,500 | -53.7% | 3.20% | -46.9% |
| CRIS | Buy | CURIS INC | $8,688,000 | +100.1% | 767,500 | +44.8% | 3.13% | +165.3% |
| SEEL | New | SEELOS THERAPEUTICS INC | $8,582,000 | – | 1,719,812 | +100.0% | 3.09% | – |
| EPIX | New | ESSA PHARMA INC | $8,337,000 | – | 287,000 | +100.0% | 3.01% | – |
| ACRS | New | ACLARIS THERAPEUTICS INC | $8,007,000 | – | 317,730 | +100.0% | 2.89% | – |
| VINC | New | VINCERX PHARMA INC | $7,604,000 | – | 394,000 | +100.0% | 2.74% | – |
| XENE | Buy | XENON PHARMACEUTICALS INC | $7,384,000 | +500.3% | 412,500 | +415.6% | 2.66% | +694.6% |
| ATHA | Buy | ATHIRA PHARMA INC | $7,360,000 | -45.3% | 400,000 | +1.8% | 2.65% | -27.5% |
| FULC | Sell | FULCRUM THERAPEUTICS INC | $7,333,000 | -8.2% | 622,500 | -8.8% | 2.64% | +21.6% |
| ARWR | Sell | ARROWHEAD PHARMACEUTICALS IN | $7,161,000 | -32.9% | 108,000 | -22.3% | 2.58% | -11.0% |
| Sell | TRILLIUM THERAPEUTICS INC | $7,105,000 | -39.8% | 661,565 | -17.6% | 2.56% | -20.3% | |
| CMRX | New | CHIMERIX INC | $6,823,000 | – | 707,830 | +100.0% | 2.46% | – |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $5,787,000 | -68.7% | 357,689 | -48.5% | 2.09% | -58.5% |
| ALT | Sell | ALTIMMUNE INC | $5,752,000 | -11.8% | 407,055 | -29.6% | 2.07% | +16.8% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $5,706,000 | -44.9% | 255,180 | -45.2% | 2.06% | -27.0% |
| VSTM | Sell | VERASTEM INC | $5,665,000 | +10.8% | 2,293,388 | -4.4% | 2.04% | +46.9% |
| JYAC | JIYA ACQUISITION CORP | $5,535,000 | -4.5% | 562,500 | 0.0% | 2.00% | +26.6% | |
| PRAX | Buy | PRAXIS PRECISION MEDICINES I | $5,053,000 | +21.4% | 154,229 | +103.9% | 1.82% | +60.8% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $4,856,000 | -49.2% | 113,161 | -32.3% | 1.75% | -32.7% |
| CBIO | Sell | CATALYST BIOSCIENCES INC | $4,735,000 | -44.7% | 939,500 | -30.8% | 1.71% | -26.8% |
| RAPT | Sell | RAPT THERAPEUTICS INC | $4,446,000 | +7.4% | 200,289 | -4.4% | 1.60% | +42.2% |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $4,392,000 | -12.6% | 392,500 | 0.0% | 1.58% | +15.8% | |
| CLSD | Buy | CLEARSIDE BIOMEDICAL INC | $3,987,000 | +16.4% | 1,614,000 | +29.1% | 1.44% | +54.3% |
| EYPT | New | EYEPOINT PHARMACEUTICALS INC | $3,872,000 | – | 381,145 | +100.0% | 1.40% | – |
| SELB | New | SELECTA BIOSCIENCES INC | $3,724,000 | – | 823,000 | +100.0% | 1.34% | – |
| CMPS | Sell | COMPASS PATHWAYS PLCsponsored ads | $3,314,000 | -78.2% | 90,000 | -71.8% | 1.20% | -71.1% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $3,089,000 | -59.6% | 97,574 | -40.8% | 1.11% | -46.5% |
| VINCW | New | VINCERX PHARMA INC*w exp 12/24/202 | $2,101,000 | – | 520,000 | +100.0% | 0.76% | – |
| RNA | Sell | AVIDITY BIOSCIENCES INC | $1,788,000 | -71.5% | 82,000 | -66.7% | 0.64% | -62.3% |
| STOK | Sell | STOKE THERAPEUTICS INC | $1,748,000 | -69.5% | 45,000 | -51.4% | 0.63% | -59.6% |
| MRTX | New | MIRATI THERAPEUTICS INC | $1,542,000 | – | 9,000 | +100.0% | 0.56% | – |
| INSM | New | INSMED INC | $1,448,000 | – | 42,500 | +100.0% | 0.52% | – |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $1,432,000 | -24.4% | 315,341 | -4.4% | 0.52% | +0.2% |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $1,396,000 | – | 14,000 | +100.0% | 0.50% | – |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $868,000 | +4.7% | 20,000 | 0.0% | 0.31% | +38.5% | |
| NVAX | Buy | NOVAVAX INC | $569,000 | +103.9% | 3,136 | +25.4% | 0.20% | +169.7% |
| PMVP | Sell | PMV PHARMACEUTICALS INC | $456,000 | -50.6% | 13,856 | -7.6% | 0.16% | -34.7% |
| CPRX | New | CATALYST PHARMACEUTICALS INC | $360,000 | – | 78,000 | +100.0% | 0.13% | – |
| NUVBWS | New | NUVATION BIO INC*w exp 07/07/202 | $249,000 | – | 93,332 | +100.0% | 0.09% | – |
| PANAWS | Exit | PANACEA ACQUISITION CORP*w exp 07/07/202 | $0 | – | -93,332 | -100.0% | -0.08% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -6,000 | -100.0% | -0.13% | – |
| KRTX | Exit | KARUNA THERAPEUTICS INC | $0 | – | -5,000 | -100.0% | -0.14% | – |
| ANNX | Exit | ANNEXON INC | $0 | – | -25,000 | -100.0% | -0.17% | – |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -107,500 | -100.0% | -0.23% | – |
| RCKT | Exit | ROCKET PHARMACEUTICALS INC | $0 | – | -20,000 | -100.0% | -0.30% | – |
| CYCC | Exit | CYCLACEL PHARMACEUTICALS INC | $0 | – | -150,000 | -100.0% | -0.32% | – |
| ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -192,500 | -100.0% | -0.36% | – |
| ONCR | Exit | ONCORUS INC | $0 | – | -53,500 | -100.0% | -0.47% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -32,500 | -100.0% | -0.98% | – |
| CCCC | Exit | C4 THERAPEUTICS INC | $0 | – | -110,000 | -100.0% | -0.99% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -120,000 | -100.0% | -1.05% | – |
| BHVN | Exit | BIOHAVEN PHARMACTL HLDG CO Lcall | $0 | – | -50,000 | -100.0% | -1.17% | – |
| CNCE | Exit | CONCERT PHARMACEUTICALS INC | $0 | – | -537,500 | -100.0% | -1.85% | – |
| REPL | Exit | REPLIMUNE GROUP INC | $0 | – | -207,500 | -100.0% | -2.15% | – |
| SURF | Exit | SURFACE ONCOLOGY INC | $0 | – | -999,500 | -100.0% | -2.51% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -283,500 | -100.0% | -3.56% | – |
| LRMR | Exit | LARIMAR THERAPEUTICS INC | $0 | – | -863,100 | -100.0% | -5.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 24 | Q1 2023 | 21.2% |
| IRIDEX CORP | 20 | Q3 2019 | 8.1% |
| ARROWHEAD PHARMACEUTICALS INC | 20 | Q2 2023 | 7.9% |
| IMMUNOMEDICS INC | 19 | Q3 2020 | 20.6% |
| VERACYTE INC | 19 | Q3 2019 | 10.1% |
| ASCENDIS PHARMA A S | 18 | Q2 2020 | 7.2% |
| XENON PHARMACEUTICALS INC | 18 | Q3 2022 | 4.6% |
| CAS MED SYS PAR $0.004 | 18 | Q1 2019 | 6.4% |
| APELLIS PHARMACEUTICALS INC | 17 | Q3 2023 | 18.4% |
| KURA ONCOLOGY INC. COMMON STOCK | 17 | Q3 2023 | 8.1% |
View ACUTA CAPITAL PARTNERS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BCLS Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| Jiya Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Larimar Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
| CATALYST BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Aadi Bioscience, Inc. | September 07, 2021 | 1,529,402 | 7.2% |
| Kadmon Holdings, Inc. | February 14, 2020 | 7,373,333 | 4.6% |
| IRIDEX CORPSold out | November 13, 2019 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2019 | 718,500 | 2.8% |
| CAS MEDICAL SYSTEMS INC | February 14, 2019 | 5,263,508 | 18.2% |
View ACUTA CAPITAL PARTNERS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View ACUTA CAPITAL PARTNERS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.